Peijia MedicalPEJMF 76 Days Payable is 233.29 as of Dec. 2025, which is 68% below its 10-year median of 718.00. GuruFocus rates PEJMF with a GF Score™ of 76/100 and a GF Value™ of $2.94. The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Peijia Medical ranks better than 82.66% on this metric.
The historical rank and industry rank for Peijia Medical's Days Payable or its related term are showing as below:
PEJMF'
s Days Payable Range Over the Past 10 Years
Min: 82.88 Med: 718 Max: 2502.09
Current: 181.33
During the past 8 years, Peijia Medical's highest Days Payable was 2502.09. The lowest was 82.88. And the median was 718.00.
PEJMF's Days Payable is ranked better than 82.66% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs PEJMF: 181.33
Peijia Medical's Days Payable
increased
from Dec. 2024 (153.32) to Dec. 2025 (233.29).
It may suggest that Peijia Medicaldelayed paying its suppliers.
Peijia Medical Days Payable Related Terms
Peijia Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Peijia Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Peijia Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peijia Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Peijia Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Peijia Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peijia Medical (PEJMF) has a Days Payable of 233.29 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Peijia Medical and its competitors. This is 68% below median its historical median of 718.00. Over the past decade, Peijia Medical's Days Payable has ranged from 82.88 to 2,502.09. According to the industry distribution chart, Peijia Medical ranks #138 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 17.3%.
Is Peijia Medical's Days Payable too high?
Peijia Medical's current Days Payable of 233.29 is 68% below median its 10-year median of 718.00. Over the past 10 years, this metric has ranged from a low of 82.88 to a high of 2,502.09. The Medical Devices & Instruments industry median Days Payable is 68.14. Peijia Medical's value of 233.29 is 242.4% above this industry median. Based on the distribution chart, Peijia Medical ranks #138 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Peijia Medical has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Peijia Medical ranks #138 out of 796 companies for Days Payable. This places Peijia Medical in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.14. Peijia Medical's value of 233.29 is 242.4% above this benchmark. Historically, Peijia Medical's own Days Payable has ranged from 82.88 to 2,502.09 over the past decade. While the company's 10-year median is 718.00 vs. the industry median of 68.14, Peijia Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peijia Medical's current Days Payable of 233.29 is 242.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Peijia Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peijia Medical's current Days Payable is 233.29, which is 68% below median its own 10-year median of 718.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current Days Payable of 233.29. The stock's GF Value™ is $2.94, compared to a current price of $1.39 — trading 52.8% below its estimated fair value. The current Days Payable is 233.29, which is 68% below median its 10-year median of 718.00 and 242.4% above the Medical Devices & Instruments industry median of 68.14. Peijia Medical's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current Days Payable is 233.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peijia Medical (PEJMF) Overvalued in 2026?
Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued.
The current stock price of $1.39 is trading 52.8% below its estimated GF Value™ of $2.94.
Key valuation signals for PEJMF:
Days Payable: 233.29 (68% below median its 10-year median of 718.00)
GF Value™: $2.94 vs. price of $1.39 (52.8% below fair value)
Industry Position: 242.4% above the Medical Devices & Instruments median (#138 of 796)
No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
76GF Score
Get the complete analysis for PEJMF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEJMF has been successfully added to your 
